Dashboard
Manage Tickers

OFIX Orthofix Medical Inc.

Nasdaq orthofix.com


$ 15.09 $ -0.19 (-1.25 %)    

Friday, 17-Oct-2025 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 15.06
$ 15.19
$ 11.50 x 10
$ 16.69 x 10
$ 15.06 - $ 15.31
$ 10.24 - $ 20.73
207,276
na
594.78M
$ 1.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 02-25-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 03-05-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-06-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-05-2022 06-30-2022 10-Q
14 05-06-2022 03-31-2022 10-Q
15 02-25-2022 12-31-2021 10-K
16 11-05-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 04-30-2021 03-31-2021 10-Q
19 02-26-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-08-2020 03-31-2020 10-Q
23 02-24-2020 12-31-2019 10-K
24 10-28-2019 09-30-2019 10-Q
25 08-05-2019 06-30-2019 10-Q
26 05-06-2019 03-31-2019 10-Q
27 02-25-2019 12-31-2018 10-K
28 10-29-2018 09-30-2018 10-Q
29 08-06-2018 06-30-2018 10-Q
30 04-30-2018 03-31-2018 10-Q
31 02-26-2018 12-31-2017 10-K
32 10-30-2017 09-30-2017 10-Q
33 08-07-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 02-27-2017 12-31-2016 10-K
36 10-31-2016 09-30-2016 10-Q
37 08-01-2016 06-30-2016 10-Q
38 04-28-2016 03-31-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-03-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

carlsmeds-personalized-spine-implants-get-significant-reimbursement-advantage
Carlsmed's Personalized Spine Implants Get...
08/18/2025 18:25:42

Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a ...

orthofix-medical-affirms-fy2025-sales-guidance-of-808000m-816000m-vs-812800m-est
Orthofix Medical Affirms FY2025 Sales Guid...
08/05/2025 11:09:41

Orthofix Medical (NASDAQ:OFIX) affirms FY2025 sales outlook from $808.000 million-$816.000 million to $808.000 million-$816.000...

orthofix-medical-q2-adj-eps-013-beats-049-estimate-sales-203121m-beat-196890m-estimate
Orthofix Medical Q2 Adj. EPS $0.13 Beats $...
08/05/2025 11:04:25

Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $(0....

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

barrington-research-initiates-coverage-on-orthofix-medical-with-outperform-rating-announces-price-target-of-16
Barrington Research Initiates Coverage On ...
06/23/2025 12:51:27

Barrington Research analyst Michael Petusky initiates coverage on Orthofix Medical (NASDAQ:OFIX) with a Outperform rating an...

orthofix-announces-global-launch-of-truelok-elevate-to-address-diabetic-ulcers-and-limb-preservation-needs
Orthofix Announces Global Launch Of TrueLo...
06/17/2025 11:13:25

jmp-securities-reiterates-market-perform-on-orthofix-medicalto-market-perform
JMP Securities Reiterates Market Perform o...
06/06/2025 14:10:16

JMP Securities analyst David Turkaly reiterates Orthofix Medical (NASDAQ:OFIX) from Market Perform to Market Perform.

orthofix-medical-lowers-fy2025-sales-guidance-from-81800m-82600m-to-80800m-81600m-vs-82198m-est
Orthofix Medical Lowers FY2025 Sales Guida...
05/06/2025 11:14:09

Orthofix Medical (NASDAQ:OFIX) lowers FY2025 sales outlook from $818.00 million-$826.00 million to $808.00 million-$816.00 mill...

orthofix-medical-q1-adj-eps-008-beats-027-estimate
Orthofix Medical Q1 Adj. EPS $(0.08) Beats...
05/06/2025 11:10:05

orthofix-medical-q1-sales-19365m-beat-19110m-estimate
Orthofix Medical Q1 Sales $193.65M Beat $1...
05/06/2025 11:03:19

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

orthofix-receives-fda-510k-clearance-and-european-ce-mark-for-the-truelok-elevate-transverse-bone-transport-system
Orthofix Receives FDA 510(k) Clearance And...
03/19/2025 12:15:29

canaccord-genuity-maintains-buy-on-orthofix-medical-maintains-24-price-target
Canaccord Genuity Maintains Buy on Orthofi...
02/26/2025 17:26:13

Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and maintains $24 price target.

roth-mkm-reiterates-buy-on-orthofix-medical-maintains-22-price-target
Roth MKM Reiterates Buy on Orthofix Medica...
02/26/2025 16:56:26

Roth MKM analyst Jason Wittes reiterates Orthofix Medical (NASDAQ:OFIX) with a Buy and maintains $22 price target.

orthofix-medical-sees-fy2025-sales-818000m-826000m-vs-84701m-est
Orthofix Medical Sees FY2025 Sales $818.00...
02/25/2025 12:04:49

Orthofix Medical (NASDAQ:OFIX) sees FY2025 sales of $818.000 million-$826.000 million vs $847.01 million analyst estimate.

orthofix-medical-q4-adj-002-beats-005-estimate-sales-21566m-beat-21271m-estimate
Orthofix Medical Q4 Adj $0.02 Beats $(0.05...
02/25/2025 12:04:23

Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0....

earnings-scheduled-for-february-25-2025
Earnings Scheduled For February 25, 2025
02/25/2025 08:32:24

top-2-health-care-stocks-that-may-crash-in-february
Top 2 Health Care Stocks That May Crash In...
02/05/2025 11:57:35

why-meta-platforms-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why Meta Platforms Shares Are Trading High...
01/30/2025 09:51:40

this-analyst-says-orthopedic-focused-orthofix-medical-is-positioned-for-growth
This Analyst Says Orthopedic-Focused Ortho...
01/22/2025 20:22:12

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and st...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION